Opportunity Information: Apply for HRSA 17 012
Apply for HRSA 17 012
- The HHS-HRSA in the health sector is offering a public funding opportunity titled "R40 MCH Secondary Data Analysis Research (SDAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.110.
- This funding opportunity was created on Jun 10, 2016 and posted on Jun 10, 2016.
- Applicants must submit their applications by Aug 19, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 10 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The R40 Maternal and Child Health (MCH) Secondary Data Analysis Research (SDAR) opportunity (HRSA-17-012) is a discretionary grant program run by the U.S. Department of Health and Human Services, Health Resources and Services Administration (HHS-HRSA), under CFDA 93.110. It was released as part of a combined announcement that included two related R40 research competitions: the MCH Field-Initiated Innovative Research Studies (FIRST) and the MCH Secondary Data Analysis Research (SDAR) program. While both tracks aim to produce findings that are generalizable and meaningful beyond a single locality, the SDAR track is specifically focused on applied maternal and child health research that relies exclusively on secondary analysis, meaning applicants must use existing national datasets and/or administrative records rather than collecting new primary data. The overarching expectation is that funded work will generate evidence with regional or national significance and practical relevance for improving health services and care delivery for MCH populations.
The SDAR program is designed to strengthen the evidence base tied to HRSA Maternal and Child Health Bureau (MCHB) priorities and investments, particularly those embedded in the transformed MCH Block Grant framework. Proposed studies are expected to align with and expand knowledge relevant to the MCH Block Grant National Performance Domains and the populations those domains cover. In other words, applicants should not only analyze existing data but do so in a way that clearly connects to the performance measurement and accountability structure used by Title V programs. The opportunity also highlights the life course perspective as an important conceptual approach that applicants may use to frame research questions. This reflects MCHB strategic direction emphasizing how health outcomes are shaped by exposures and interventions across stages of life, and how maternal, infant, child, and adolescent health are linked over time.
In addition to fitting within at least one MCH Block Grant National Performance Domain, applications are expected to address at least one of MCHB's Strategic Research Issues. The announcement names examples of those issues, including improving public health systems and infrastructure, reducing health disparities, increasing the quality of and access to care, and promoting the health of MCH populations. This alignment is not treated as a minor preference; it is built directly into the review process. Specifically, meeting the expectation to address at least one national performance domain and one strategic research issue is part of Review Criterion 1 (Need), which is scored for up to 10 points. That structure signals that reviewers will be looking for a clear rationale for why the question matters to MCHB priorities, how it fills an evidence gap, and why the results would be useful for programs serving MCH populations.
Funded recipients are expected to carry out several core activities. First, they must conduct applied or translational research using secondary analyses of existing national databases and/or administrative records, selecting analytic methods that match the stated aims. Second, they must produce new knowledge on critical MCH issues that advances the evidence base and supports translation of findings into practice, not just academic insight. Third, dissemination is a central requirement: awardees are expected to develop and publish at least two peer-reviewed manuscripts. Beyond journal publication, recipients must also show a credible plan for moving findings into real-world use by communicating results to key audiences such as researchers, clinicians and other providers, State Title V agencies and related programs serving HRSA/MCHB populations, policymakers, families, and the broader public. The announcement explicitly encourages multiple dissemination formats tailored to those audiences, including conference presentations, newsletters, webcasts, fact sheets, infographics, policy briefs, and online outreach through websites and social media when appropriate. The underlying theme is that SDAR projects should not end with statistical results; they should be designed from the start to influence practice, programs, and decision-making in maternal and child health.
From the posted opportunity details, the original and current closing date for this specific notice was August 19, 2016, and HRSA anticipated making around 10 awards. The award ceiling is listed as 0 in the provided record, which often indicates that the ceiling was either unspecified in that summary field or defined elsewhere in the full notice. Eligibility is summarized broadly as "Others," with clarification intended to be provided in the full eligibility section of the announcement. Overall, the SDAR opportunity is best understood as a targeted funding mechanism for policy- and program-relevant MCH research that leverages existing large-scale data sources, explicitly aligns with Title V performance and MCHB strategic priorities, and produces publishable results alongside practical, audience-specific dissemination intended to improve services and outcomes for maternal and child health populations.
Frequently Asked Questions (FAQs): R40 MCH Secondary Data Analysis Research (SDAR) (HRSA-17-012)
What is the R40 Maternal and Child Health (MCH) Secondary Data Analysis Research (SDAR) opportunity?
The R40 MCH Secondary Data Analysis Research (SDAR) opportunity (HRSA-17-012) is a discretionary grant program run by the U.S. Department of Health and Human Services, Health Resources and Services Administration (HHS-HRSA), under CFDA 93.110. It supports applied maternal and child health research that relies exclusively on secondary data analysis using existing national datasets and/or administrative records.
Which agency administers this grant program?
This program is administered by HHS-HRSA (Health Resources and Services Administration), within the broader Maternal and Child Health Bureau (MCHB) context described in the opportunity.
What is CFDA 93.110 and how does it relate to this opportunity?
CFDA 93.110 is the Catalog of Federal Domestic Assistance listing associated with this opportunity. The SDAR program is identified under CFDA 93.110 in the provided information.
Is SDAR part of a larger funding announcement?
Yes. The SDAR opportunity was released as part of a combined announcement that included two related R40 research competitions: MCH Field-Initiated Innovative Research Studies (FIRST) and MCH Secondary Data Analysis Research (SDAR).
How is the SDAR track different from the FIRST track?
Both tracks aim to produce findings that are generalizable and meaningful beyond a single locality. The SDAR track is specifically focused on applied MCH research that relies exclusively on secondary analysis of existing national datasets and/or administrative records, rather than collecting new primary data.
Does SDAR allow collecting new primary data?
No. SDAR is explicitly focused on secondary analysis only. Applicants must use existing national datasets and/or administrative records rather than collecting new primary data.
What kinds of data sources are expected for SDAR projects?
Projects are expected to use existing national databases and/or administrative records. The emphasis is on leveraging large-scale, already-existing data sources rather than generating new data through primary collection.
What is the overarching purpose of the SDAR program?
The program is designed to generate evidence with regional or national significance and practical relevance for improving health services and care delivery for maternal and child health populations, strengthening the evidence base tied to MCHB priorities and investments.
What does HRSA/MCHB expect funded SDAR projects to produce?
Funded projects are expected to produce new knowledge on critical MCH issues that advances the evidence base and supports translation of findings into practice, not just academic insight. Dissemination is central, including at least two peer-reviewed manuscripts and communications tailored to key audiences.
What does it mean that findings should be "generalizable and meaningful beyond a single locality"?
It means the research should produce results that matter at a broader level (regional or national significance) rather than being limited to a single community, site, or local program context.
How should an SDAR study align with the MCH Block Grant framework?
Proposed studies are expected to align with and expand knowledge relevant to the transformed MCH Block Grant framework, including clear connections to the MCH Block Grant National Performance Domains and the populations those domains cover.
What are the MCH Block Grant National Performance Domains, and why do they matter here?
The opportunity expects applicants to fit their study within at least one MCH Block Grant National Performance Domain and to connect the analysis to the performance measurement and accountability structure used by Title V programs. Reviewers are looking for a clear rationale for why the question matters to these priorities and how it fills an evidence gap.
Do applications need to address MCHB Strategic Research Issues?
Yes. Applications are expected to address at least one of MCHB's Strategic Research Issues, in addition to fitting within at least one National Performance Domain.
What are examples of MCHB Strategic Research Issues mentioned in the opportunity?
Examples listed include improving public health systems and infrastructure, reducing health disparities, increasing the quality of and access to care, and promoting the health of MCH populations.
How important is alignment with a National Performance Domain and a Strategic Research Issue for peer review?
It is built directly into the review process. Meeting the expectation to address at least one National Performance Domain and one Strategic Research Issue is part of Review Criterion 1 (Need), scored for up to 10 points.
What is Review Criterion 1 (Need) and what does it emphasize?
Review Criterion 1 (Need) is a scored criterion worth up to 10 points. It emphasizes a clear rationale for why the research question matters to MCHB priorities, how the project fills an evidence gap, and why results would be useful for programs serving MCH populations, including alignment with at least one National Performance Domain and one Strategic Research Issue.
Is a life course perspective relevant to SDAR applications?
Yes. The opportunity highlights the life course perspective as an important conceptual approach that applicants may use to frame research questions, reflecting MCHB's emphasis on how outcomes are shaped across stages of life and how maternal, infant, child, and adolescent health are linked over time.
What are the required activities for SDAR awardees?
Recipients are expected to: (1) conduct applied or translational research using secondary analyses of existing national databases and/or administrative records using appropriate analytic methods; (2) produce new knowledge on critical MCH issues with an emphasis on translation into practice; and (3) carry out robust dissemination, including publishing at least two peer-reviewed manuscripts and communicating findings to key audiences in multiple formats.
How many peer-reviewed manuscripts are expected?
The announcement expects awardees to develop and publish at least two peer-reviewed manuscripts.
Beyond journals, what kinds of dissemination formats are encouraged?
The opportunity encourages dissemination formats tailored to different audiences, including conference presentations, newsletters, webcasts, fact sheets, infographics, policy briefs, and online outreach through websites and social media when appropriate.
Who are the key audiences that SDAR projects should communicate findings to?
Key audiences named include researchers, clinicians and other providers, State Title V agencies and related programs serving HRSA/MCHB populations, policymakers, families, and the broader public.
Is dissemination considered a central requirement for SDAR projects?
Yes. Dissemination is described as a central requirement, and projects are expected to be designed from the start to influence practice, programs, and decision-making in maternal and child health.
What is the closing date for this specific notice?
Based on the posted opportunity details provided, the original and current closing date for this notice was August 19, 2016.
How many awards did HRSA anticipate making?
HRSA anticipated making around 10 awards for this opportunity.
What is the award ceiling for this opportunity?
The award ceiling is listed as 0 in the provided record. This often indicates the ceiling was unspecified in that summary field or defined elsewhere in the full notice, but the specific ceiling amount is not provided in the information shown here.
Who is eligible to apply?
Eligibility is summarized broadly as "Others," with clarification intended to be provided in the full eligibility section of the announcement. The specific eligible applicant types are not detailed in the information provided.
What does "discretionary grant program" mean in this context?
The opportunity is described as a discretionary grant program run by HRSA, meaning it is a competitive funding program administered by the agency under the terms of the announcement.
What kinds of research does SDAR prioritize (applied vs. basic research)?
SDAR prioritizes applied or translational maternal and child health research using secondary analyses, with an expectation that findings will be practically relevant for improving health services and care delivery and will support translation into practice.
What is Title V and how does it connect to this opportunity?
The opportunity emphasizes alignment with the performance measurement and accountability structure used by Title V programs, specifically through the MCH Block Grant National Performance Domains. Applicants are expected to connect their analyses to those domains and the populations they cover.
Browse more opportunities from the same category: Health
Next opportunity: THIS IS NOT A REQUEST FOR APPLICATIONS - Accessiblity Modifications to NPS Temporary Visitor Center at Pullman National Monument
Previous opportunity: NOTICE OF INTENT TO FUND WITHOUT COMPETITION - Centennial Youth Maritime Explorers - PEVI
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HRSA 17 012
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (HRSA 17 012) also looked into and applied for these:
| Funding Opportunity |
|---|
| R40 MCH Field-Initiated Innovative Research Studies (FIRST) Apply for HRSA 17 011 Funding Number: HRSA 17 011 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| PPHF 2016: Preventive Health and Health Services Block Grant – Preventive Health and Health Services Block Grant Apply for CDC RFA OT16 1600PPHF16 Funding Number: CDC RFA OT16 1600PPHF16 Agency: HHS-CDC-OSTLTS Category: Health Funding Amount: Case Dependent |
| Emerging Science and Technology in Transplantation (U01) Apply for RFA AI 16 042 Funding Number: RFA AI 16 042 Agency: HHS-NIH11 Category: Health Funding Amount: $250,000 |
| Transforming Clinical Practice Initiative (TCPI) Support and Alignment Network (SAN) 2.0 Apply for CMS 1L1 16 001 Funding Number: CMS 1L1 16 001 Agency: HHS-CMS Category: Health Funding Amount: $2,500,000 |
| Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R24) Apply for PAR 16 322 Funding Number: PAR 16 322 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases (R21) Apply for RFA HL 17 015 Funding Number: RFA HL 17 015 Agency: HHS-NIH11 Category: Health Funding Amount: $150,000 |
| Limited Competition: NIDCR Supplements to NCATS CTSA Programs for Scholars Pursing Dental, Oral and Craniofacial Clinical and Translational Research Career Development (Admin Supp) Apply for RFA DE 17 008 Funding Number: RFA DE 17 008 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Guidance for Supplemental CDC/NCCDPHP/BRFSS Funding Opportunity Announcement (FOA) CDC-RFA-DP15-15130201SUPPPPHF16 Behavioral Risk Factor Surveillance System (BRFSS) Apply for CDC RFA DP15 15130201SUPPPPHF16 Funding Number: CDC RFA DP15 15130201SUPPPPHF16 Agency: HHS-CDC-NCCDPHP Category: Health Funding Amount: $160,000 |
| Limited Competition: Administrative Supplements to Enhance Network Capacity: Collaborative Opportunities for the CTSA Program (Admin Supp) Apply for PA 16 328 Funding Number: PA 16 328 Agency: HHS-NIH11 Category: Health Funding Amount: $300,000 |
| Embassy Conakry Ebola-Related Projects Apply for CKY PAS FY16 002 Funding Number: CKY PAS FY16 002 Agency: DOS-AF Category: Health Funding Amount: $10,000 |
| National HIV Surveillance System (NHSS) Apply for CDC RFA PS13 130205CONT17 Funding Number: CDC RFA PS13 130205CONT17 Agency: HHS-CDC-NCHHSTP Category: Health Funding Amount: Case Dependent |
| Science of Behavior Change: Use-inspired Basic Research to Optimize Behavior Change Interventions and Outcomes (Admin Supp) Apply for PA 16 334 Funding Number: PA 16 334 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| National Accessibility Technical Assistance and Support Apply for P16AS00252 Funding Number: P16AS00252 Agency: DOI-NPS Category: Health Funding Amount: $100,000 |
| Strengthening of Public Health Programs to address Communicable and Non-Communicable Diseases in the Republic of Kenya including the Presidents Emergency Plan for AIDS Relief (PEPFAR). Apply for CDC RFA GH16 1703 Funding Number: CDC RFA GH16 1703 Agency: HHS-CDC-CGH Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 17 050 Funding Number: HRSA 17 050 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| NHLBI Pilot Program to Provide Regulatory Support to SBIR/STTR Awardees Developing Medical Devices (Diagnostics and Therapeutics) (Admin Supp) Apply for PA 16 335 Funding Number: PA 16 335 Agency: HHS-NIH11 Category: Health Funding Amount: $5,000 |
| Urban Indian Education and Research Organization Cooperative Agreement Program Apply for HHS 2016 IHS UIHP3 0001 Funding Number: HHS 2016 IHS UIHP3 0001 Agency: HHS-IHS Category: Health Funding Amount: $800,000 |
| Planning Grant for NINDS Morris K. Udall Parkinson's Disease Research Center Without Walls (R34) Apply for RFA NS 16 024 Funding Number: RFA NS 16 024 Agency: HHS-NIH11 Category: Health Funding Amount: $150,000 |
| Native American Independent Living Demonstration Project Apply for HHS 2016 ACL AOD IL 0184 Funding Number: HHS 2016 ACL AOD IL 0184 Agency: HHS-ACL Category: Health Funding Amount: $250,000 |
| Tuberculosis regional Training and Medical Consultation Centers,National Center for HIV, Hepatitis, Sexually Transmitted Diseases and Tuberculosis Apply for CDC RFA PS13 130404CONT17 Funding Number: CDC RFA PS13 130404CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HRSA 17 012", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.